Nature's Sunshine Products Inc. (United States) is listed on the Nasdaq and has a market capitalization of $373.95 million, with shareholders equity totaling $166.92 .
The company employs approximately 837 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Nature's Sunshine Products Inc. reported $489.79 in revenue, generating net income of $19.89 .
Key financial metrics include a P/E ratio of 18.80, a price-to-book (P/B) ratio of 2.24, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker NATR.